The Healthy on MSN21h
What Is a Breast Cancer Rash? A Doctor ExplainsA breast lump is the most common and recognized symptom of breast cancer, according to a 2023 study published in Preventive ...
Annual cancer statistics report identifies persistent racial and ethnic disparities and increases in certain cancers in women ...
Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with ...
The approval is based on findings from the phase 3, multicenter, open-label, randomized TROPION-Breast01 trial.
And, in fact, this study showed that the additional palbociclib to this kind of treatment was able to significantly prolong PFS from the start of the maintenance treatment with a benefit in terms of ...
The overall average breast cancer incidence rate in the U.S. was 131.8 per 100,000 and the overall average breast cancer mortality rate was 19.3 per 100,000. Among women in the U.S., breast cancer ...
TipRanks on MSN13h
AstraZeneca’s Datroway approved in U.S. for HER2-negative breast cancer patientsDXd, has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor HR-positive, HER2-negative breast cancer who have received prior endocrine-based ...
More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback